B-CELL PROLYMPHOCYTIC LEUKEMIA
Clinical trials for B-CELL PROLYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL PROLYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL PROLYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at returning blood cancers
Disease control OngoingThis early-stage study tests a personalized cell therapy for adults with certain B-cell blood cancers (like lymphomas and leukemias) that have come back after prior treatment. Doctors take a patient's own white blood cells, modify them in the lab to better recognize and attack ca…
Matched conditions: B-CELL PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New drug duo targets hard-to-treat blood cancers in early trial
Disease control OngoingThis early-phase study tests the safety and best dose of a new drug called pevonedistat when given with ibrutinib for people with chronic lymphocytic leukemia or non-Hodgkin lymphoma that has returned or no longer responds to standard treatments. The study enrolls about 18 adults…
Matched conditions: B-CELL PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC